SpringWorks Therapeutics Inc (SWTX)
36.55
+1.84
(+5.30%)
USD |
NASDAQ |
Nov 14, 16:00
36.55
0.00 (0.00%)
After-Hours: 20:00
SpringWorks Therapeutics Cash and Short Term Investments (Quarterly): 383.88M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 383.88M |
| March 31, 2024 | 436.58M |
| December 31, 2023 | 479.20M |
| September 30, 2023 | 422.42M |
| June 30, 2023 | 476.71M |
| March 31, 2023 | 528.14M |
| December 31, 2022 | 592.21M |
| September 30, 2022 | 651.94M |
| June 30, 2022 | 334.54M |
| March 31, 2022 | 348.27M |
| December 31, 2021 | 373.50M |
| Date | Value |
|---|---|
| September 30, 2021 | 427.91M |
| June 30, 2021 | 462.78M |
| March 31, 2021 | 477.41M |
| December 31, 2020 | 508.48M |
| September 30, 2020 | 276.82M |
| June 30, 2020 | 291.23M |
| March 31, 2020 | 311.08M |
| December 31, 2019 | 327.65M |
| September 30, 2019 | 343.82M |
| June 30, 2019 | 185.29M |
| December 31, 2018 | 45.65M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
276.82M
Minimum
Sep 2020
651.94M
Maximum
Sep 2022
426.88M
Average
427.91M
Median
Sep 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Ocugen Inc | 38.70M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |
| Theriva Biologics Inc | 16.59M |